Profile data is unavailable for this security.
Mergers & acquisitions
Acquired company | ABBV:NYQ since announced | Transaction value |
---|---|---|
Cerevel Therapeutics Holdings Inc | 33.82% | 8.62bn |
ImmunoGen Inc | 39.69% | 10.22bn |
Data delayed at least 15 minutes, as of Sep 21 2024 00:00 BST.
Holder | Shares | % Held |
---|---|---|
Caixa DTVM SAas of 31 May 2024 | 418.33k | 0.00% |
Bram Bradesco Asset Management S/A DTVMas of 31 May 2024 | 57.28k | 0.00% |
Daycoval Asset Management Administra��o de Recursos Ltda.as of 31 May 2024 | 4.29k | 0.00% |
XP Allocation Asset Management Ltda.as of 31 May 2024 | 2.07k | 0.00% |
More ▼
Data from 31 May 2024 - 11 Sep 2024Source: FactSet Research Systems Inc.